DR. JOHN ALVIN STEWART M.D. NPI 1265423313

NPI Details

DR. John Alvin Stewart, M.D. is a dermatology in Opelika, AL with 50 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. DR. John Alvin Stewart, M.D. NPI is 1265423313. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Graduation Year:1976

The provider's business location address is:

122 N 20TH ST
BLDG 25
OPELIKA, AL
ZIP 36801-442
Phone: (334) 749-5604
Fax: (334) 749-3040

The NPI 1265423313 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:17282)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:11440)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11622)
• Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11301)
• Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11302)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Shaving of skin growth of body, arms, or legs, 0.5 cm or less (HCPCS:11300)
• Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11401)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Removal of cancer skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11601)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:11310)
• Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:11621)
• Removal of noncancer skin growth of body, arms, or legs, 0.5 cm or less (HCPCS:11400)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Punch biopsy, first skin growth (HCPCS:11104)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less (HCPCS:11305)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm (HCPCS:17283)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11311)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11641)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:11306)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm (HCPCS:11623)
• Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11422)
• Fungal culture (mold or yeast) of skin, hair, or nail (HCPCS:87101)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm (HCPCS:17273)
• Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less (HCPCS:11420)
• Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm (HCPCS:17263)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm (HCPCS:11643)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:17271)
• Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11441)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11307)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 10/28/2005 and was last updated on 8/10/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.